As part of our market update series, please see the summary below of what we saw in the convertible market in Q4 2022 along with some year-end takeaways. Although Q3 and Q4 were relatively active (with ~$10 billion of issuance each quarter), 2022 total volume (~$29 billion) was the lowest over the ... >>>Read More
Q3 2022 Convertible Market Review
As part of our market update series, please see the summary below of what we saw in the convertible market in Q3 2022. Notably, Q3 volumes were the highest of the year totaling $10.5bn - accounts for over 50% of the YTD volumes Healthcare issuance continues to be the largest driver of volumes with ... >>>Read More
Are the Financing Markets Still Open? – An Update as We Head into Fall
As part of our ongoing market update series, we wanted to take a look at the current state of the convertible markets as we approach the end of summer. In this blog post, we review the recent trading and issuance dynamics of the convertible market and what that means for issuers contemplating ... >>>Read More
Q2 2022 Convertible Market Review
As part of our market update series, please see the summary below of what we saw in the convertible market in Q2 2022. New Issuance. The convertible market continues to see a slow down in new issue paper with 10 deals in Q2 (all debt) worth $3.4bn. This level of issuance is the lowest in the past ... >>>Read More
Convertible Issuance in Life Sciences: How, When and Why
In the first installment of our three-part series on the financing landscape for life sciences issuers, we covered the evolution of the typical life sciences IPO. In the second installment, we covered post-IPO financing dynamics and the importance of laying the foundation for successful capital ... >>>Read More
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 13
- Next Page »